Homocysteine Remethylation
Homocysteine Remethylation - Related Videos
17:12
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry (CCMS)
0 Views •
Cited by 13 •
2010
Capture Compounds are trifunctional small molecules to reduce the complexity of the proteome by functional reversible small molecule-protein interaction followed by photo-crosslinking and purification. Here we use a Capture Compound with S-adenosyl-L-homocysteine-binding as selectivity function to isolate methyltransferases from an Escherichia coli whole cell lysate and identify them by MS.
FAQs
The pathway depends on coordinated availability of vitamin B12 and 5-methyltetrahydrofolate. Methionine synthase uses these components to move a methyl group onto homocysteine, regenerating methionine. If either required nutrient is deficient, this reaction can be disrupted, providing a biochemical explanation for why homocysteine may accumulate.
Vitamin B12 and 5-methyltetrahydrofolate do not simply serve as background nutrients in this reaction. They are the components that enable methionine synthase to transfer the methyl group required for homocysteine conversion. Their roles make nutritional status clinically relevant when investigators examine disrupted remethylation and the biochemical basis of elevated homocysteine.
Once methionine is regenerated, it can be used to produce S-adenosylmethionine, commonly called SAM, a major cellular methyl donor. This links homocysteine remethylation with the broader maintenance of methylation capacity rather than treating homocysteine as an isolated metabolite. Studying the pathway therefore connects changes in homocysteine with cellular methyl-group availability.
Impaired enzyme activity can disturb homocysteine remethylation even when the pathway is considered intact in principle. Because methionine synthase performs the methyl-group transfer, reduced effectiveness of this enzyme offers a mechanistic explanation for altered homocysteine concentrations. Clinical research uses this relationship to investigate metabolic disturbances and their possible association with health risks.
Clinical investigations can use the pathway as a framework for biochemical assessment by examining homocysteine concentrations in relation to folate or vitamin B12 deficiency, impaired enzyme activity, and other metabolic disturbances. The purpose is not merely to record one metabolite, but to interpret its concentration within the reactions that regenerate methionine and support methylation capacity.
An elevated homocysteine concentration may prompt investigation of whether remethylation is being affected by folate deficiency, vitamin B12 deficiency, impaired enzyme activity, or another related disturbance. The pathway does not by itself establish a specific cause or health outcome; instead, it provides a biochemical framework for evaluating possible contributors and associated risks.